VF
ORIC icon

Virtu Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Virtu Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,372
Closed -$225K – 1736
2024
Q1 		$225K Buy
+16,372
New +$194K 0.02% 732
2023
Q4 		– Sell
-19,461
Closed -$118K – 1890
2023
Q3 		$118K Buy
19,461
+7,630
+64% +$62.5K 0.01% 794
2023
Q2 		$92K Sell
11,831
-7,793
-40% -$44.3K 0.01% 1055
2023
Q1 		$112K Buy
+19,624
New +$103K 0.01% 943
2022
Q2 		– Sell
-10,548
Closed -$56K – 1932
2022
Q1 		$56K Buy
+10,548
New +$95K ﹤0.01% 1102
2020
Q3 		– Sell
-6,167
Closed -$208K – 1378
2020
Q2 		$208K Buy
+6,167
New +$197K 0.02% 705

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return